[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zee-Cheng et al., 1974 - Google Patents

Experimental antileukemic agents. Coralyne, analogs, and related compounds

Zee-Cheng et al., 1974

Document ID
6339086165892527499
Author
Zee-Cheng K
Paull K
Cheng C
Publication year
Publication venue
Journal of Medicinal Chemistry

External Links

Snippet

Conclusions We can tentatively draw some conclusions regarding the antibacterial activity ofcephalosporins and penicillins. We have considered a two-step mechanism for the inhibit- ing reaction: first, reversible binding of drug to the en-zyme; second, irreversible formation of …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00

Similar Documents

Publication Publication Date Title
Zee-Cheng et al. Experimental antileukemic agents. Coralyne, analogs, and related compounds
JP3346562B2 (en) PCP receptor / ligand and drugs containing them
US3072530A (en) Therapeutic indoles for psychic stimulation and relief of mental depression
MXPA06005701A (en) 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases.
CA3078312A1 (en) Chemical compounds
DE60317889T2 (en) ANTIVIRAL BICYCLO 4.4.0 DERIVATIVES
AU2006322187A1 (en) Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
WO2011127833A1 (en) Benzoheterocyclic compounds, preparation methods and uses thereof
EP2755976B1 (en) 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors
BR112019024376A2 (en) compound of general formula (i), or pharmaceutically acceptable salts thereof, pharmaceutical composition and use of the compounds or pharmaceutically acceptable salts thereof
CN103739553B (en) N-substituted imidazole carboxylate chiral compound containing ether side chain, preparation method and application
JPS63225374A (en) Thiazole derivative, its production and composition containing same
BR112017009012B1 (en) BENZO RING DERIVATIVES OF SIX LIMBS AS A DPP-4 INHIBITOR AND USE THEREOF
NO813066L (en) ISOQINOLINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS, CONTENTS AND THEIR USE
CN105473568A (en) 1,7-naphthyridine derivatives
JP2018138609A (en) Naphthyridinedione derivatives
CN106117242A (en) Tetrahydric thiapyran miazines derivative and preparation method and application
JP4601038B2 (en) Indolylmaleimides
CN109134463B (en) β -carboline type 5 phosphodiesterase inhibitor and preparation method and application thereof
US4818772A (en) Derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes: methods of synthesis and utilization as medicines
BRPI0807928A2 (en) METHODS TO IDENTIFY A LYN KINASE ACTIVATOR, AND TO TREAT DIABETES IN A HUMAN, KIT, AND, COMPOSITION
FI57949C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ANALYSIS OF 4-OXO-6,7,8,9-TETRAHYDROPYRIDO (1,2-A) PYRIMIDINDERIVAT
KR20240004495A (en) Isoquinolone compounds and their uses
JPH0585553B2 (en)
CN104364240A (en) Drug for preventing or treating mycobacterial diseases